The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age

Noni E. MacDonald, Jane C. McDonald, Natalie A. Bridger, Jane C. Finlay, Susanna Martin, Heather Onyett, Joan L. Robinson, Marina I. Salvadori, Otto G. Vanderkooi, Upton D. Allen, Michael Brady, Charles P.S. Hui, Nicole Le Saux, Dorothy L. Moore, Nancy Scott-Thomas, John S. Spika

Résultat de recherche: Articleexamen par les pairs

Résumé

Influenza is a serious problem for infants <6 months of age, whose hospitalization rates for influenza and associated illness are comparable with rates in the elderly. Because influenza vaccines are not effective in this age group, the optimal evidence-based strategy is to administer trivalent inactivated influenza vaccines during pregnancy. Immunizing with trivalent inactivated influenza vaccines in the second and third trimester is well studied and safe, not only providing protection for the pregnant woman and her infant <6 months of age, but also for the fetus by decreasing the risk for low birth weight.

Langue d'origineEnglish
Pages (de-à)15-16
Nombre de pages2
JournalCanadian Journal of Infectious Diseases and Medical Microbiology
Volume26
Numéro de publication1
Statut de publicationPublished - janv. 1 2015

Note bibliographique

Publisher Copyright:
© 2015 Canadian Peadiatric Society. All rights reserved.

ASJC Scopus Subject Areas

  • Microbiology (medical)
  • Infectious Diseases

Empreinte numérique

Plonger dans les sujets de recherche 'The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age'. Ensemble, ils forment une empreinte numérique unique.

Citer